Metagenomi, Inc. Common Stock Cash Flow Reinvestment Rate
Metagenomi, Inc. Common Stock cash flow reinvestment rate. Metagenomi, Inc. Common Stock (MGX) has a Cash Flow Reinvestment Rate of 0.63x as of December 2022, reinvesting $42.38 Million (capex $3.51 Million plus investments $-38.87 Million) from operating cash flow of $67.73 Million. Explore Metagenomi, Inc. Common Stock (MGX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Metagenomi, Inc. Common Stock (2021–2022)
Cash flow reinvestment rate of Metagenomi, Inc. Common Stock from 2021 to 2022. Historical reinvestment intensity for Metagenomi, Inc. Common Stock across 2 annual periods. Explore Metagenomi, Inc. Common Stock (MGX) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Metagenomi, Inc. Common Stock Cash Flow Reinvestment Rate by Year (2021–2022)
Metagenomi, Inc. Common Stock cash flow reinvestment rate by year from 2021 to 2022. Year-by-year capital reinvestment analysis for Metagenomi, Inc. Common Stock. For the full cash flow conversion analysis, see Metagenomi, Inc. Common Stock (MGX) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 4.58x | $136.18 Million | $29.72 Million | $13.98 Million | ▲ +43.9% |
| 2021 | 3.18x | $77.22 Million | $24.26 Million | $2.90 Million | — |